Mesenchymal Stem Cells Loaded with p5, Derived from CDK5 Activator p35, Inhibit Calcium-Induced CDK5 Activation in Endothelial Cells
The potential use of stem cells as therapeutics in disease has gained momentum over the last few years and recently phase-I clinical trials have shown favourable results in treatment of a small cohort of acute stroke patients. Similarly, they have been used in preclinical models drug-loaded for the...
Saved in:
Main Authors: | Wen-Hui Fang (Author), Shant Kumar (Author), Garry McDowell (Author), David Smith (Author), Jurek Krupinski (Author), Peter Olah (Author), Raid Saleem Al-Baradie (Author), Mohammad Othman Al-Rukban (Author), Eugene Bogdan Petcu (Author), Mark Slevin (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resveratrol inhibits Cdk5 activity through regulation of p35 expression
by: Kulkarni Ashok B, et al.
Published: (2011) -
Absence of the Cdk5 activator p35 causes adult-onset neurodegeneration in the central brain of Drosophila
by: Svetlana Trunova, et al.
Published: (2012) -
Altered expression of the Cdk5 activator-like protein, Cdk5α, causes neurodegeneration, in part by accelerating the rate of aging
by: Joshua Spurrier, et al.
Published: (2018) -
Cell-Penetrating Fragments of the Cdk5 Regulatory Subunit Are Protective in Models of Neurodegeneration
by: Jan Liman, et al.
Published: (2010) -
No association of CDK5 genetic variants with Alzheimer's disease risk
by: Combarros Onofre, et al.
Published: (2009)